About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 908907, 10 pages
Review Article

Metabolism, Physiological Role, and Clinical Implications of Sphingolipids in Gastrointestinal Tract

1Department of Physiology, Medical University of Bialystok, Mickiewicza Street 2C, 15-222 Białystok, Poland
2Department of Public Health, Medical University of Bialystok, Szpitalna Street 37, 15-295 Białystok, Poland
3Regional Blood Center, M. Skłodowskiej–Curie Street 23, 15-950 Białystok, Poland

Received 9 April 2013; Revised 30 June 2013; Accepted 2 August 2013

Academic Editor: Atsushi Sakuraba

Copyright © 2013 Krzysztof Kurek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Krzysztof Kurek, Patrycja Wiesiołek-Kurek, Dominika M. Piotrowska, Bartłomiej Łukaszuk, Adrian Chabowski, and Małgorzata Żendzian-Piotrowska, “Inhibition of Ceramide De Novo Synthesis with Myriocin Affects Lipid Metabolism in the Liver of Rats with Streptozotocin-Induced Type 1 Diabetes,” BioMed Research International, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Núria Canela, Pol Herrero, Sílvia Mariné, Pedro Nadal, Maria Rosa Ras, Pedro Nadal, Miguel Ángel Rodríguez, and Lluís Arola, “Analytical methods in sphingolipidomics: Quantitative and profiling approaches in food analysis,” Journal of Chromatography A, 2015. View at Publisher · View at Google Scholar
  • David Rojo, María J Gosalbes, Rafaela Ferrari, Ana E Pérez-Cobas, Ester Hernández, Rosa Oltra, Javier Buesa, Amparo Latorre, Coral Barbas, Manuel Ferrer, and Andrés Moya, “Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses,” The ISME Journal, 2015. View at Publisher · View at Google Scholar
  • Jung H. Suh, and Julie D. Saba, “Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire,” Translational Cancer Research, vol. 4, no. 5, pp. 469–483, 2015. View at Publisher · View at Google Scholar
  • Nabanita Chatterjee, Subhadip Das, Dipayan Bose, Somenath Banerjee, Tarun Jha, and Krishna Das Saha, “Leishmanial lipid affords protection against oxidative stress induced hepatic injury by regulating inflammatory mediators and confining apoptosis progress,” Toxicology Letters, vol. 232, no. 2, pp. 499–512, 2015. View at Publisher · View at Google Scholar
  • Krzysztof Kurek, Bartłomiej Łukaszuk, Agnieszka Świdnicka-Siergiejko, Paweł Rogalski, Eugeniusz Wróblewski, Adrian Chabowski, Andrzej Dąbrowski, and Małgorzata Żendzian-Piotrowska, “Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia,” Lipids, 2015. View at Publisher · View at Google Scholar
  • Dominik Vogt, and Holger Stark, “Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism,” Medicinal Research Reviews, 2016. View at Publisher · View at Google Scholar
  • Krzysztof Kurek, Marta Garbowska, Dominika M. Ziembicka, Bartłomiej Łukaszuk, Jakub Rogowski, Adrian Chabowski, Jan Górski, and Małgorzata Żendzian-Piotrowska, “Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes,” Advances in Medical Sciences, 2016. View at Publisher · View at Google Scholar
  • Fu-Chen Huang, “De Novo sphingolipid synthesis is essential for Salmonella-induced autophagy and human beta-defensin 2 expression in intestinal epithelial cells,” Gut Pathogens, vol. 8, no. 1, 2016. View at Publisher · View at Google Scholar